Clinical Trial Update: Botulinum Toxin A Injectable Solution in the Management of Bruxism: A Clinical Trial Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating botulinum toxin A injectable solution for management of nocturnal bruxism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Bruxism

Drugs mentioned

• Botulinum toxin A injectable solution (botulinum toxin type A)

Snippet

Sponsor: Riyadh Colleges of Dentistry and Pharmacy | Conditions: Nocturnal Bruxism | Phase 2 | Status: UNKNOWN